InnoPharmax Inc. (4172.TWO)
TWD 17.1
(-0.87%)
TWD 17.1
(-0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -48.57 Million | -100.07 Million | -50.02 Million | -47.37 Million | -42.45 Million |
| Net Income | -70.83 Million | -103.18 Million | -92.96 Million | -43.89 Million | -87.89 Million |
| Depreciation & Amortization | 7.24 Million | 8.37 Million | 9.47 Million | 14.22 Million | 12.92 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 1.75 Million | 2.36 Million | 660 Thousand | 323 Thousand | - |
| Change in working capital | 2.33 Million | -13.19 Million | 14.86 Million | -33.9 Million | 27.21 Million |
| Other non-cash items | -1.27 Million | -726 Thousand | -612 Thousand | -171 Thousand | 5.29 Million |
| Investing Cash Flow | -50 Million | 31.32 Million | -36.6 Million | -20.03 Million | 18.75 Million |
| Investments in PPE | -397 Thousand | -128 Thousand | -1.45 Million | -1.86 Million | - |
| Acquisitions | - | - | 52 Thousand | - | 29.83 Million |
| Investment purchases | -48.9 Million | 32.71 Million | -36.26 Million | -18.17 Million | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -702 Thousand | -1.29 Million | 1.06 Million | -20.03 Million | 18.75 Million |
| Financing Cash Flow | 97.4 Million | 18.77 Million | -4.26 Million | 122.75 Million | 80.41 Million |
| Debt repayment | -11.77 Million | -23.27 Million | -20 Million | -4.34 Million | -4.33 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 113.6 Million | - | 20.15 Million | - | - |
| Other Financing Activities | 101.83 Million | 23.27 Million | 152 Thousand | 127.09 Million | 4.75 Million |
| Accounts receivables | -6.95 Million | 500 Thousand | 6.46 Million | -13.53 Million | 10.25 Million |
| Accounts payables | 5.72 Million | - | - | - | - |
| Inventory | 7.78 Million | -14.44 Million | 29.18 Million | -22.13 Million | -546 Thousand |
| Other working capital | -4.21 Million | 745 Thousand | 6.08 Million | -16.48 Million | 17.5 Million |
| Cash at beginning of period | 40.52 Million | 90.5 Million | 181.39 Million | 126.05 Million | 69.33 Million |
| Cash at end of period | 39.35 Million | 40.52 Million | 90.5 Million | 181.39 Million | 126.05 Million |
| Capital Expenditure | -397 Thousand | -128 Thousand | -1.45 Million | -1.86 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -1.16 Million | -49.98 Million | -90.89 Million | 55.34 Million | 56.72 Million |
| Free Cash Flow | -48.96 Million | -100.2 Million | -51.47 Million | -49.23 Million | -42.45 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.27 Million | -21.27 Million | -20.48 Million | -70.83 Million | -20.48 Million | -14.92 Million |
| Depreciation & Amortization | 1.68 Million | 1.68 Million | 1.77 Million | 7.24 Million | 1.77 Million | 1.82 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 268 Thousand | - | 657 Thousand | 1.75 Million | 657 Thousand | 222 Thousand |
| Change in working capital | 1.46 Million | 1.46 Million | -10.34 Million | 2.33 Million | -10.34 Million | 8.65 Million |
| Other non-cash items | 8.51 Million | 8.78 Million | 6.06 Million | -1.27 Million | 6.06 Million | 2.28 Million |
| Investing Cash Flow | 28.24 Million | 28.24 Million | -2.18 Million | -50 Million | -2.18 Million | -22.82 Million |
| Investments in PPE | - | - | -198.5 Thousand | -397 Thousand | -198.5 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -48.9 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 28.24 Million | 28.24 Million | -1.98 Million | -702 Thousand | -1.98 Million | -22.82 Million |
| Financing Cash Flow | -1.78 Million | -1.78 Million | 4.64 Million | 97.4 Million | 4.64 Million | 44.05 Million |
| Debt repayment | - | - | - | -11.77 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 113.6 Million | - | - |
| Other Financing Activities | -1.78 Million | -1.78 Million | 4.64 Million | 101.83 Million | 4.64 Million | 44.05 Million |
| Accounts receivables | -195 Thousand | -195 Thousand | -922.5 Thousand | -6.95 Million | -922.5 Thousand | -2.55 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 2.39 Million | 2.39 Million | -8.19 Million | 7.78 Million | -8.19 Million | 12.08 Million |
| Other working capital | -728.5 Thousand | -728.5 Thousand | -1.23 Million | -4.21 Million | -1.23 Million | -874.5 Thousand |
| Cash at beginning of period | - | - | - | 40.52 Million | - | - |
| Cash at end of period | 17.12 Million | 17.12 Million | -19.87 Million | 39.35 Million | -19.87 Million | 19.28 Million |
| Capital Expenditure | - | - | -198.5 Thousand | -397 Thousand | -198.5 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 17.12 Million | 17.12 Million | -19.87 Million | -1.16 Million | -19.87 Million | 19.28 Million |
| Free Cash Flow | -9.33 Million | -9.33 Million | -22.53 Million | -48.96 Million | -22.53 Million | -1.94 Million |
MOTHERSON
4901
BHOOY
CREATIVE
2730
UNIDT